ISIN | IE00BKWQ0H23 |
---|---|
Valor Number | 24767202 |
Bloomberg Global ID | |
Fund Name | SPDR MSCI Europe Health Care UCITS ETF EUR |
Fund Provider |
State Street Investment Management
Kalanderplatz 5, 8045 Zürich E-Mail: spdrsswitzerland@statestreet.com Web: www.statestreet.com/im spdrsswitzerland@statestreet.com (ETF Business) |
Fund Provider | State Street Investment Management |
Representative in Switzerland |
State Street Bank GmbH, München, Zweigniederlassung Zürich Zürich Phone: +41 44 560 50 00 |
Distributor(s) | State Street Global Advisors |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Accumulation |
Home Country | Ireland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | Combination of redemption commission charged by the fund management company and transaction fee charged by the fund |
Investment Strategy *** | The investment objective of the Fund is to track the performance of European large and midsized companies in the Health Care sector. |
Peculiarities |
Current Price * | 208.90 EUR | 04.09.2025 |
---|---|---|
Previous Price * | 208.77 EUR | 03.09.2025 |
52 Week High * | 240.74 EUR | 09.09.2024 |
52 Week Low * | 182.04 EUR | 09.04.2025 |
NAV * | 208.90 EUR | 04.09.2025 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 679,334,714 | |
Unit/Share Assets *** | 679,334,714 | |
Trading Information SIX |
YTD Performance | -0.38% |
31.12.2024 - 04.09.2025
31.12.2024 04.09.2025 |
---|---|---|
YTD Performance (in CHF) | -0.64% |
31.12.2024 - 04.09.2025
31.12.2024 04.09.2025 |
1 month | +6.65% |
04.08.2025 - 04.09.2025
04.08.2025 04.09.2025 |
3 months | +0.50% |
04.06.2025 - 04.09.2025
04.06.2025 04.09.2025 |
6 months | -9.61% |
04.03.2025 - 04.09.2025
04.03.2025 04.09.2025 |
1 year | -14.19% |
04.09.2024 - 04.09.2025
04.09.2024 04.09.2025 |
2 years | +1.82% |
04.09.2023 - 04.09.2025
04.09.2023 04.09.2025 |
3 years | +14.37% |
05.09.2022 - 04.09.2025
05.09.2022 04.09.2025 |
5 years | +35.81% |
04.09.2020 - 04.09.2025
04.09.2020 04.09.2025 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
AstraZeneca PLC | 14.41% | |
---|---|---|
Novartis AG Registered Shares | 14.04% | |
Roche Holding AG | 13.35% | |
Novo Nordisk AS Class B | 10.57% | |
Sanofi SA | 6.38% | |
Essilorluxottica | 5.35% | |
GSK PLC | 4.68% | |
Lonza Group Ltd | 2.91% | |
Haleon PLC | 2.58% | |
argenx SE | 2.52% | |
Last data update | 31.08.2025 |
TER *** | 0.18% |
---|---|
TER date *** | 31.03.2025 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 0.18% |
Ongoing Charges *** | 0.18% |
SRRI ***
|
|
SRRI date *** | 31.08.2025 |